PDQ®がん用語辞書 英語版
ofatumumab
- 原文
a monoclonal antibody being studied in the treatment of certain types of b-cell cancers including chronic lymphocytic leukemia (cll) and follicular non-hodgkin lymphoma. monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. ofatumumab binds to cd20, a protein on the surface of normal b cells and most b-cell tumors. also called humax-cd20.
調べた例文を記録して、効率よく覚えましょう
Weblio会員無料で登録できます
履歴機能
過去に調べた単語を確認できる
語彙力診断
診断回数が4回に増加
マイ単語帳
便利な学習機能付き
マイ例文帳
文章で意味を理解できる
ウィキペディア英語版
出典：Wikipedia
Ofatumumab
出典:『Wikipedia』 (2011/05/18 16:39 UTC 版)
英語による解説
ウィキペディア英語版からの引用
- 引用
Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab and has also shown potential in treating follicular non-Hodgkin’s lymphoma, diffuse large B cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis. Ofatumumab has also received conditional approval in Europe for the treatment of refractory chronic lymphocytic leukemia. This makes ofatumumab the first marketing application for an antibody produced by Genmab, as well as the first human monoclonal antibody which targets the CD20 molecule that will be available for patients with refractory CLL.
- Copyright ©2004-2026 Translational Research Informatics Center. All Rights Reserved.
財団法人先端医療振興財団 臨床研究情報センター
- Copyright (C) 2026 ライフサイエンス辞書プロジェクト
- Wikipedia
- Text is available under Creative Commons Attribution-ShareAlike (CC-BY-SA) and/or GNU Free Documentation License (GFDL).
Weblio英和・和英辞典に掲載されている「Wikipedia英語版」の記事は、WikipediaのOfatumumab (改訂履歴)の記事を複製、再配布したものにあたり、Creative Commons Attribution-ShareAlike (CC-BY-SA)もしくはGNU Free Documentation Licenseというライセンスの下で提供されています。
